1. Silber B, Riegelman S. Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma. J Pharmacol Exp Ther 1980;215:643-648.
2. Li X, Zeng S. Stereoselective propranolol metabolism in two drug induced rat hepatic microsomes. World J Gastroenterol 2000;6:74-78.
3. Masubuchi Y, Hosokawa S, Horie T, Suzuki T, Ohmori S, Kitada M, Narimatsu S. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab Dispos 1994;22:909-915.
4. Luan LJ, Shao Q, Zhang XH, Zeng S. Effects of microsome enzyme induced by phenobarbarbital on the stereoselectivity of recemic propranolol glucuronidation metabolism. Zhejiang DaXue XueBao YiXueBan 2004;33:7-10.
5. Zhou HH, Shay SD, Wood AJ. Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians. Chin Med J (Engl) 1993;106:898-902.